Citation Impact

Citing Papers

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Serotonin Transporter Genetic Variation and the Response of the Human Amygdala
2002 StandoutScience
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Striatal dopamine transporter density in major depression
1999
LV Thrombus Detection by Routine Echocardiography
2011
Increased Striatal Dopamine Transmission in Schizophrenia: Confirmation in a Second Cohort
1998
The detection of preclinical Parkinson's disease: What is the role of positron emission tomography?
1993
Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors or Are Selective for D4 Receptors
1997
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients
2000
Adverse Health Effects of Marijuana Use
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
An integrated view of pathophysiological models of schizophrenia
1999
Neutrophils at work
2014 Standout
A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placement
2002
Glutamate uptake
2001 Standout
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
2001
Synthesis of [123I]IBZM: a reliable procedure for routine clinical studies
1999
Imaging D2 Receptor Occupancy by Endogenous Dopamine in Humans
1997
Staging of brain pathology related to sporadic Parkinson’s disease
2002 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The adolescent brain and age-related behavioral manifestations
2000 Standout
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers
2011
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Neurochemical Sensitization in the Pathophysiology of Schizophrenia: Deficits and Dysfunction in Neuronal Regulation and Plasticity
1997
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
2001 Standout
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
2000 StandoutNobel
Network interactions in schizophrenia — therapeutic implications
2000 StandoutNobel
Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach
1998
The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer's disease and vascular dementia
2003
Beautiful Faces Have Variable Reward Value
2001 Standout
Natural history of left ventricular thrombi: Their appearance and resolution in the posthospitalization period of acute myocardial infarction
1990
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Anatomically distinct dopamine release during anticipation and experience of peak emotion to music
2011 Standout
Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans
1999
Neurochemical brain imaging investigations of schizophrenia
1999
Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication
1995
Improvement in the Diagnosis of Abscesses Associated with Endocarditis by Transesophageal Echocardiography
1991 Standout
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
2000 Standout
A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity
2000
Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“ecstasy”) users: relationship to cognitive performance
2008
Glutamate Modulation of Dopamine Measured in Vivo with Positron Emission Tomography (PET) and 11C-Raclopride in Normal Human Subjects
1998
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 StandoutNobel
Major Depressive Disorder
2008 Standout
Decreased Benzodiazepine Receptor Binding in Prefrontal Cortex in Combat-Related Posttraumatic Stress Disorder
2000
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
In Vivo Imaging of Neurotransmitter Systems Using Radiolabeled Receptor Ligands
1997
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography
1998
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Increased dopamine transmission in schizophrenia: relationship to illness phases
1999
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys
1999
The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies
2000
SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder
2000
Neurocircuitry of Addiction
2009 Standout
Alterations of Benzodiazepine Receptors in Type II Alcoholic Subjects Measured With SPECT and [123I]Iomazenil
1998
The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies
2001 Standout
Elevated Central Serotonin Transporter Binding Availability in Acutely Abstinent Cocaine-Dependent Patients
2000
Dopamine, learning and motivation
2004 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Fluorine in medicinal chemistry
2007 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Anticipation of Increasing Monetary Reward Selectively Recruits Nucleus Accumbens
2001 Standout
Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
2000
Effects of full-dose heparin anticoagulation on the development of left ventricular thrombosis in acute transmural myocardial infarction
1986
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.
1987
Transesophageal Echocardiography
1988
Guidelines for the Primary Prevention of Stroke
2014 Standout
Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.
1994
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
A glutamatergic deficiency model of schizophrenia
1999 StandoutNobel
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Increased embolic risk in patients with left ventricular thrombi.
1987
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation
2011
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
1996
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
1997
Wound Healing: A Cellular Perspective
2018 Standout
Cost-Effectiveness of Echocardiography to Identify Intracardiac Thrombus among Patients with First Stroke or Transient Ischemic Attack
2007
Imaging neurochemical endophenotypes: promises and pitfalls
2001
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Kinetic Modeling of [11C]Raclopride: Combined PET-Microdialysis Studies
1997
SPECT Quantification of [123I]Iomazenil Binding to Benzodiazepine Receptors in Nonhuman Primates: II. Equilibrium Analysis of Constant Infusion Experiments and Correlation with in vitro Parameters
1994
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Effect of early anticoagulation on the frequency of left ventricular thrombi after anterior wall acute myocardial infarction
1986
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies
1999
Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).
1988 Standout
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
NETosis: how vital is it?
2013
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
1996

Works of Eileen O. Smith being referenced

Amphetamine‐stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates
1992
Cryopreservable neutrophil surrogates: Granule-poor, motile cytoplasts from polymorphonuclear leukocytes home to inflammatory lesions in vivo
2006
Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primates
1992
The acetylcholine releaser linopirdine increases parietal regional cerebral blood flow in Alzheimer's disease
1997
SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primates
1993
Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT
1991
Evaluation of the monoamine uptake site ligand [131I]methyl 3β-(4-Iodophenyl)-tropane-2β-carboxylate ([123I]β-CIT) in non-human primates: Pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI
1993
Left atrial mass: Diagnostic value of transesophageal 2-dimensional echocardiography and indium-111 platelet scintigraphy
1983
Detection of platelet deposition at the site of peripheral balloon angioplasty using indium-111 platelet scintigraphy
1985
Detection of Active Left Ventricular Thrombosis during Acute Myocardial Infarction Using Indium-111 Platelet Scintigraphy
1984
Comparison of Indium-111 Platelet Scintigraphy and Two-Dimensional Echocardiography in the Diagnosis of Left Ventricular Thrombi
1982
Rankless by CCL
2026